Neurogene Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Neurogene Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Neurogene Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$6.52M, a 6197% decline year-over-year.
  • Neurogene Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $92.5M, a 39% increase from 2022.
  • Neurogene Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $66.5M, a 8989% increase from 2021.
  • Neurogene Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $732K, a 99.1% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $92.5M +$26M +39% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 $66.5M +$65.8M +8989% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $732K -$76.4M -99.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $77.1M -$5.1M -6.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $82.2M +$81.7M +14328% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $570K +$147K +34.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $423K -$70.7M -99.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $71.1M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.